Acrivon Therapeutics, Inc. (ACRV)
1.86
+0.03
(+1.64%)
USD |
NASDAQ |
Jan 15, 16:00
1.87
+0.01
(+0.54%)
After-Hours: 20:00
Acrivon Therapeutics Total Liabilities (Quarterly): 16.70M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aclarion, Inc. | 0.6997M |
| Vistagen Therapeutics, Inc. | 14.59M |
| Spero Therapeutics, Inc. | 27.68M |
| Humacyte, Inc. | 96.26M |
| PMGC Holdings, Inc. | 6.447M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 145.30M |
| Shareholders Equity (Quarterly) | 128.60M |
| Debt to Equity Ratio | 0.0232 |
| Current Ratio | 8.754 |
| Net Debt Paydown Yield | 0.43% |